Literature DB >> 3707413

Recording pattern visual evoked potentials under chloral hydrate sedation.

K W Wright, K J Eriksen, T J Shors, J P Ary.   

Abstract

Accurate assessment of visual function in infants and preverbal children is difficult because of the dependence on vision tests that require the patient's cooperation. In an attempt to resolve this problem, we evaluated pattern visual evoked potentials (PVEPs) obtained on infants under chloral hydrate sedation. Ten patients were studied--four with unilateral amblyopia, three with suspected amblyopia, and three without amblyopia. Patients with amblyopia showed robust and reproducible responses from the sound eye, while responses from the amblyopic eye were significantly diminished (amplitude ratio less than or equal to 0.63). The PVEP responses from patients without amblyopia were large in amplitude and symmetrical between fellow eyes (amplitude ratio greater than 0.9). In two eyes with normal vision, optically fogging the patterned stimulus image substantially reduced the PVEP response, establishing a sensitivity to pattern images rather than changes in the overall luminance. We have thus determined that the PVEP can be reliably obtained under chloral hydrate sedation and that these responses, like PVEP responses taken in the awake state, reflect the presence of amblyopia and image clarity. Use of the PVEP with chloral hydrate sedation may prove clinically useful for detecting amblyopia in uncooperative infants and children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707413     DOI: 10.1001/archopht.1986.01050170108032

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  The optic nerve in children with craniosynostosis. A pre and post surgical evaluation.

Authors:  S Gupta; S Ghose; M Rohatgi; A Kumar; A Das
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 2.  Electrophysiologic testing techniques for children.

Authors:  A B Fulton; E E Hartmann; R M Hansen
Journal:  Doc Ophthalmol       Date:  1989-04       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.